Pfizer Profile

37.53
USD 0.15  0.40%
100%
83%

Acquisition by Ian Read of 84959 shares of Pfizer subject to Rule 16b-3

Pfizer insider trading alert for grant of common stock by Ian Read, Senior Vice President, on July 16, 2018. This event was filed by the entity with SEC on 2010-03-01. Statement of changes in beneficial ownership - SEC Form 4. Ian Read is currently serves as chairman, ceo and chairman of executive committee of Pfizer [view details]   

Pfizer Summary

Pfizer is a pharmaceutical company in the United States and is among one of the largest. Big pharma is what it is typically called here in the U.S. and is looked at in many different lights. [more]
Pfizer (PFE) is traded on BATS Exchange in USA. It is located in NEW YORK U.S.A and employs 90,200 people. Pfizer is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with total capitalization of 217.66 B. Pfizer runs under Healthcare sector within Pharmaceuticals And Biosciences industry. This company has 5.85 B outstanding shares of which 64.69 M shares are at this time shorted by investors with about 3.28 days to cover shorted positions. PFIZER INC has about 11.47 B in cash with 12.37 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.96.
Check Pfizer Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Odds Below 37.53HorizonTargetOdds Above 37.53
95.72%30 days 37.53 4.11%
Based on normal probability distribution, the odds of Pfizer to move above current price in 30 days from now is nearly 4.11% (This Pfizer probability density function shows the probability of Pfizer Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Fisher Asset Management LlcCommon Shares39.4 M1.4 B
Hexavest IncCommon Shares6 M216.9 M
View Pfizer Diagnostics

Selected Pfizer Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Pfizer Against Markets

Risk Adjusted
Performance Score (0 to 100)
21 
Chance of
Financial Distress (0 to 100%)
19 
Equity ratings for Pfizer are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug Manufacturers - Major classification in USA and traded on New York Stock Exchange. It employs 90200 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Pfizer SEC Filings
Pfizer SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NamePfizer
ChairmanIan ReadView All
Thematic Classifications
Active Investing Ideas
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
RegionNorth America
LocationNEW YORK U.S.A
Business Address235 East 42nd Street
Foreign Associates
ExchangeBATS Exchange
CIK Number0000078003
ISINUS7170811035
CUSIP717991939
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.pfizer.com
Phone212 733 2323
CurrencyUSD - US Dollar

Current Sentiment - PFE

Pfizer Investor Sentiment
Predominant part of Macroaxis users are at this time bullish on Pfizer. What is your perspective on investing in Pfizer? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Pfizer Corporate Directors

Helen Hobbs Independent Director
Shantanu Narayen Director
James Smith Director
Additionally take a look at Your Equity Center. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.